| Literature DB >> 25794615 |
Oleg Laptenko1, Idit Shiff2, Will Freed-Pastor1, Andrew Zupnick1, Melissa Mattia1, Ella Freulich1, Inbal Shamir2, Noam Kadouri2, Tamar Kahan2, James Manfredi3, Itamar Simon4, Carol Prives5.
Abstract
DNA binding by numerous transcription factors including the p53 tumor suppressor protein constitutes a vital early step in transcriptional activation. While the role of the central core DNA binding domain (DBD) of p53 in site-specific DNA binding has been established, the contribution of the sequence-independent C-terminal domain (CTD) is still not well understood. We investigated the DNA-binding properties of a series of p53 CTD variants using a combination of in vitro biochemical analyses and in vivo binding experiments. Our results provide several unanticipated and interconnected findings. First, the CTD enables DNA binding in a sequence-dependent manner that is drastically altered by either its modification or deletion. Second, dependence on the CTD correlates with the extent to which the p53 binding site deviates from the canonical consensus sequence. Third, the CTD enables stable formation of p53-DNA complexes to divergent binding sites via DNA-induced conformational changes within the DBD itself.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25794615 PMCID: PMC6221458 DOI: 10.1016/j.molcel.2015.02.015
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970